Literature DB >> 31455614

Plasma oxyphytosterol concentrations are not associated with CVD status in Framingham Offspring Study participants.

Sabine Baumgartner1, Rouyanne T Ras2, Elke A Trautwein2, Maurice C J M Konings3, Ronald P Mensink3, Jogchum Plat3.   

Abstract

Dietary plant sterols, such as campesterol and sitosterol, reduce plasma cholesterol concentrations, but any relationship to plaque development and CVD remains unclear. Some epidemiologic studies have suggested that elevated plasma plant sterol concentrations are atherogenic, including the Framingham Offspring Study that identified a positive association between plant sterol concentrations and CVD status. We hypothesized that this suggested atherogenicity relates to the oxidation status of plant sterols (i.e., concentrations of plasma oxyphytosterols). Therefore, in the Framingham Offspring Study cohort, we measured plasma oxyphytosterol concentrations in 144 patients with documented CVD and/or more than 50% carotid stenosis and 383 matched controls. We analyzed plasma oxyphytosterol concentrations by GC/MS/MS and performed conditional logistic regression analysis to determine associations between plasma plant sterol or oxyphytosterol concentrations and CVD status. We found that higher total cholesterol (TC)-standardized campesterol concentrations [odds ratio (OR): 2.36; 95% CI: 1.60, 3.50] and higher sitosterol concentrations (OR: 1.47; 95% CI: 1.09, 1.97) were significantly associated with increased CVD risk, as in the earlier study. However, the sum of absolute oxyphytosterol concentrations (OR: 0.99; 95% CI: 0.81, 1.21) and the sum of TC-standardized oxyphytosterol concentrations (OR: 0.98; 95% CI: 0.80, 1.19) were not associated with an increased CVD risk. Results were comparable for individual absolute and TC-standardized oxycampesterol and oxysitosterol concentrations. Plasma nonoxidized TC-standardized sitosterol and campesterol concentrations showed weak or no correlations with oxyphytosterol concentrations, while all individual plasma concentrations of oxyphytosterol correlated with each other. In conclusion, circulating plasma oxyphytosterols are not associated with CVD risk in the Framingham Offspring Study.
Copyright © 2019 Baumgartner et al.

Entities:  

Keywords:  cardiovascular disease risk factors; cholesterol; lipids; plant sterols

Mesh:

Substances:

Year:  2019        PMID: 31455614      PMCID: PMC6824488          DOI: 10.1194/jlr.RA119000274

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  37 in total

1.  Consumption of plant sterol-enriched foods and effects on plasma plant sterol concentrations--a meta-analysis of randomized controlled studies.

Authors:  Rouyanne T Ras; Harry Hiemstra; Yuguang Lin; Mario A Vermeer; Guus S M J E Duchateau; Elke A Trautwein
Journal:  Atherosclerosis       Date:  2013-08-19       Impact factor: 5.162

2.  The relationships of phytosterols and oxyphytosterols in plasma and aortic valve cusps in patients with severe aortic stenosis.

Authors:  Hans-Frieder Schött; Alexandra Luister; Constanze Husche; Hans-Joachim Schäfers; Michael Böhm; Jogchum Plat; Dieter Lütjohann; Ulrich Laufs; Oliver Weingärtner
Journal:  Biochem Biophys Res Commun       Date:  2014-03-12       Impact factor: 3.575

Review 3.  Plasma noncholesterol sterols: current uses, potential and need for standardization.

Authors:  Dylan S Mackay; Peter J H Jones
Journal:  Curr Opin Lipidol       Date:  2012-06       Impact factor: 4.776

4.  Vascular effects of oxysterols and oxyphytosterols in apoE -/- mice.

Authors:  Oliver Weingärtner; Constanze Husche; Hans F Schött; Timo Speer; Michael Böhm; Charlotte M Miller; Florence McCarthy; Jogchum Plat; Dieter Lütjohann; Ulrich Laufs
Journal:  Atherosclerosis       Date:  2015-02-26       Impact factor: 5.162

5.  Alterations in cholesterol homeostasis are associated with coronary heart disease in patients with aortic stenosis.

Authors:  Oliver Weingärtner; Nadja Weingärtner; Bruno Scheller; Dieter Lütjohann; Stefan Gräber; Hans-Joachim Schäfers; Michael Böhm; Ulrich Laufs
Journal:  Coron Artery Dis       Date:  2009-09       Impact factor: 1.439

6.  Oxidation of sitosterol and transport of its 7-oxygenated products from different tissues in humans and ApoE knockout mice.

Authors:  Hans-Frieder Schött; Sabine Baumgartner; Constanze Husche; Alexandra Luister; Silvia Friedrichs; Charlotte M Miller; Florence O McCarthy; Jogchum Plat; Ulrich Laufs; Oliver Weingärtner; Dieter Lütjohann
Journal:  J Steroid Biochem Mol Biol       Date:  2016-04-27       Impact factor: 4.292

7.  Oxidised plant sterols as well as oxycholesterol increase the proportion of severe atherosclerotic lesions in female LDL receptor+/ - mice.

Authors:  Jogchum Plat; Elke Theuwissen; Constanze Husche; Dieter Lütjohann; Marion J J Gijbels; Mike Jeurissen; Ronit Shiri-Sverdlov; Ingeborg van der Made; Ronald P Mensink
Journal:  Br J Nutr       Date:  2013-06-18       Impact factor: 3.718

8.  Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD.

Authors:  Nirupa R Matthan; Michael Pencina; Jane M LaRocque; Paul F Jacques; Ralph B D'Agostino; Ernst J Schaefer; Alice H Lichtenstein
Journal:  J Lipid Res       Date:  2009-05-12       Impact factor: 5.922

Review 9.  Metabolic syndrome: definitions and controversies.

Authors:  Eva Kassi; Panagiota Pervanidou; Gregory Kaltsas; George Chrousos
Journal:  BMC Med       Date:  2011-05-05       Impact factor: 8.775

10.  The effects of vitamin E or lipoic acid supplementation on oxyphytosterols in subjects with elevated oxidative stress: a randomized trial.

Authors:  Sabine Baumgartner; Ronald P Mensink; Guido R Haenen; Aalt Bast; Christoph J Binder; Otto Bekers; Constanze Husche; Dieter Lütjohann; Jogchum Plat
Journal:  Sci Rep       Date:  2017-11-10       Impact factor: 4.379

View more
  1 in total

1.  Serum Concentration of Plant Sterol Oxidation Products (POP) Compared to Cholesterol Oxidation Products (COP) after Intake of Oxidized Plant Sterols: A Randomised, Placebo-Controlled, Double-Blind Dose‒Response Pilot Study.

Authors:  Yuguang Lin; Wieneke P Koppenol; Diny Knol; Mario A Vermeer; Harry Hiemstra; Silvia Friedrichs; Dieter Lütjohann; Elke A Trautwein
Journal:  Nutrients       Date:  2019-09-30       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.